<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-55077</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0092738</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Endocrine system</subject><subj-group><subject>Pancreas</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Cancer epidemiology</subject></subj-group></subj-group><subj-group><subject>Gastroenterology and hepatology</subject></subj-group><subj-group><subject>Women's health</subject><subj-group><subject>Maternal health</subject><subj-group><subject>Pregnancy</subject></subj-group></subj-group><subj-group><subject>Obstetrics and gynecology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies</article-title>
<alt-title alt-title-type="running-head">Meta-Analysis of Parity and Pancreatic Cancer</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guan</surname><given-names>Hong-Bo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>Lang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>Qi-Jun</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhu</surname><given-names>Jingjing</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gong</surname><given-names>Tingting</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University, Shenyang, China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>Department of Educational Psychology, University of Minnesota, Minneapolis, Minnesota, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Real</surname><given-names>Francisco X.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Centro Nacional de Investigaciones Oncológicas (CNIO), Spain</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">hong_bo_guan@163.com</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: H-BG LW Q-JW J-JZ T-TG. Performed the experiments: H-BG LW Q-JW. Analyzed the data: H-BG Q-JW. Contributed reagents/materials/analysis tools: H-BG LW Q-JW J-JZ T-TG. Wrote the paper: H-BG. Approved the final manuscript: H-BG LW Q-JW J-JZ T-TG. Had full access to all of the data and the final responsibility for the decision to submit for publication: H-BG.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>21</day><month>3</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>3</issue>
<elocation-id>e92738</elocation-id>
<history>
<date date-type="received"><day>31</day><month>12</month><year>2013</year></date>
<date date-type="accepted"><day>24</day><month>2</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Guan et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Previous epidemiologic studies have reported inconsistent results between parity and pancreatic cancer (PC) risk. To our knowledge, a comprehensive and quantitative assessment of this association has not been conducted.</p>
</sec><sec>
<title>Methods</title>
<p>Relevant published studies of parity and PC were identified using MEDLINE (PubMed) and Web of Science databases until November 2013. Two authors (H-BG and LW) independently assessed eligibility and extracted data. Eleven prospective and 11 case-control studies reported relative risk (RR) estimates and 95% confidence intervals (CIs) of PC associated with parity. Fixed- and random-effects models were used to estimate the summary RR depending on the heterogeneity of effects.</p>
</sec><sec>
<title>Results</title>
<p>The summary RR for PC comparing the highest versus lowest parity was 0.86 (95% CI: 0.73–1.02; <italic>Q</italic> = 50.49, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup> = 58.4%). Significant inverse associations were also observed in the studies that adjusted for cigarette smoking (RR = 0.81; 95% CI: 0.68–0.98), Type 2 diabetes mellitus (RR = 0.83; 95% CI: 0.75–0.93), and those that included all confounders or important risk factors (RR = 0.85; 95% CI: 0.76–0.96). Additionally, in the dose-response analysis, the summary RR for per one live birth was 0.97 (95% CI: 0.94–1.01; <italic>Q</italic> = 62.83, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup> = 69.8%), which also indicated a borderline statistically significant inverse effect of parity on PC risk. No evidence of publication bias and significant heterogeneity between subgroups were detected by meta-regression analyses.</p>
</sec><sec>
<title>Conclusion</title>
<p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.</p>
</sec></abstract>
<funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Pancreatic cancer (PC) is the fourth leading cause of cancer death for both sexes in the United States <xref ref-type="bibr" rid="pone.0092738-Siegel1">[1]</xref>, although the incidence rate is 30–50% higher in men than women <xref ref-type="bibr" rid="pone.0092738-Anderson1">[2]</xref>. Based on current knowledge, the incidence rate difference between the sexes cannot be completely attributed to established risk factors including cigarette smoking, overweight and obesity, history of diabetes mellitus (DM), history of pancreatitis, and non-O blood group <xref ref-type="bibr" rid="pone.0092738-Anderson1">[2]</xref>. Given the evidence from <italic>in vitro</italic> and <italic>in vivo</italic> studies <xref ref-type="bibr" rid="pone.0092738-Benz1">[3]</xref>–<xref ref-type="bibr" rid="pone.0092738-Bourhis1">[4]</xref>, it has been hypothesized that hormone-related or reproductive factors related to estrogen exposure may play a role in the etiology of PC.</p>
<p>Among the reproductive factors that have been investigated, parity (the number of livebirths in a woman's lifetime), is less likely to be prone to recall bias and misclassification <xref ref-type="bibr" rid="pone.0092738-Dahabreh1">[5]</xref>, but the results of epidemiologic studies have been conflicting which might be attributed to limited statistical power or inadequate adjustment for confounders <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>–<xref ref-type="bibr" rid="pone.0092738-Miller1">[32]</xref>. Though a previous review has focused on this topic <xref ref-type="bibr" rid="pone.0092738-Wahi1">[33]</xref>, to our knowledge, a comprehensive and quantitative assessment of the association between parity and PC risk has not been conducted. Therefore, we carried out a dose-response meta-analysis on epidemiologic studies published up to November 2013 to quantify the association between parity and PC.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Literature search</title>
<p>We carried out a comprehensive literature search using MEDLINE (PubMed) and Web of Science from database initiation until November 12, 2013. The search was limited to published studies of humans by using the following search key words and Medical Subject Headings terms: (parity OR pregnancy OR livebirth OR reproductive OR reproduction OR reproductive factors) AND (pancreas OR pancreatic) AND (cancer OR neoplasm OR carcinoma OR tumor). We also reviewed the references of all included studies for additional publications. We followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) for conducting and reporting meta-analyses <xref ref-type="bibr" rid="pone.0092738-Moher1">[34]</xref>–<xref ref-type="bibr" rid="pone.0092738-Guan1">[36]</xref>.</p>
</sec><sec id="s2b">
<title>Study selection criteria</title>
<p>Published studies were included if they 1) used a case-control or prospective study design; 2) evaluated the association between parity and PC risk; and 3) presented hazard ratio (HR), odds ratio (OR), or relative risk (RR) estimates with 95% confidence intervals (CI), standard errors (SE) or data necessary to calculate these. When multiple publications from the same study were available, we used the publication with the largest number of cases and most applicable information. After excluding 1045 and 47 articles based on screening of titles or abstracts, respectively, we identified 27 potentially relevant articles for further full text review (<xref ref-type="fig" rid="pone-0092738-g001">Figure 1</xref>) <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>–<xref ref-type="bibr" rid="pone.0092738-Miller1">[32]</xref>. One article was excluded because of duplicate reports from the same study population <xref ref-type="bibr" rid="pone.0092738-LaVecchia1">[29]</xref>, 4 articles were excluded because they did not report usable or enough data of risk estimate <xref ref-type="bibr" rid="pone.0092738-Kvale1">[26]</xref>, <xref ref-type="bibr" rid="pone.0092738-Kalapothaki1">[28]</xref>, <xref ref-type="bibr" rid="pone.0092738-Haines1">[31]</xref>–<xref ref-type="bibr" rid="pone.0092738-Miller1">[32]</xref>. Since less than 5% of the PC patients survive more than 5 years after diagnosis, thus we did not excluded the studies <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref>–<xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref> reported the risk estimates between parity and PC mortality.</p>
<fig id="pone-0092738-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092738.g001</object-id><label>Figure 1</label><caption>
<title>Selection of studies for inclusion in meta-analysis.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092738.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s2c">
<title>Data abstraction</title>
<p>For each eligible study, two investigators (H-BG and LW) independently performed the eligibility evaluation and data abstraction. The disagreements were discussed and resolved by consensus or by involving a third reviewer (Q-JW) for adjudication. Data abstracted from each study were: author list, year of publication, study region and design, study sample size (number of cases and controls or cohort size), range of follow-up for cohort studies, exposure and outcome assessment including parity categories, study-specific adjusted estimates with their 95% CIs for the highest versus lowest parity, and factors matched by or adjusted for in the design or data analysis. If multiple estimates of the association were available, we abstracted the estimate that adjusted for the most covariates.</p>
</sec><sec id="s2d">
<title>Statistical analysis</title>
<p>The study-specific adjusted RRs were used as the measure of association across studies. Because the absolute risk of PC is low, we assumed that estimates of ORs from case-control studies and risk, rate or hazard ratios from prospective studies were all valid estimates of the RR and we therefore report all results as the RR for simplicity. For studies that did not use the category with lowest parity as the reference <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref>, we used the effective count method proposed by Hamling et al <xref ref-type="bibr" rid="pone.0092738-Hamling1">[37]</xref> to recalculate the RRs.</p>
<p>For the dose-response analysis which calculated parity as a continuous variable, we used the method proposed by Greenland et al. <xref ref-type="bibr" rid="pone.0092738-Greenland1">[38]</xref> to compute study-specific slopes (linear trends) and 95% CIs from the natural logs of the RRs and CIs across categories of parity. This method requires that the distribution of cases, person-years of non-cases and the RRs with the variance estimates for at least three quantitative exposure categories are known. For studies that reported the parity number by ranges we estimated the midpoint in each category by calculating the average of the lower and upper bound. When the highest category did not have an upper bound we assumed that the width of the open ended interval was the same as that of the adjacent interval. When the lowest category did not have a lower bound we set the lower bound to zero. The dose-response results in the forest plots are presented based on increments of 1 live birth for parity. We examined a potential nonlinear dose-response relationship between parity and PC using fractional polynomial models <xref ref-type="bibr" rid="pone.0092738-Royston1">[39]</xref>. We determined the best-fitting second-order fractional polynomial regression model as the one with the lowest deviance. A likelihood ratio test was used to assess the difference between the nonlinear and linear models to test for nonlinearity <xref ref-type="bibr" rid="pone.0092738-Bagnardi1">[40]</xref>.</p>
<p>We evaluated heterogeneity of RRs across studies by using the Cochrane <italic>Q</italic> statistic and the <italic>I</italic><sup>2</sup> statistic <xref ref-type="bibr" rid="pone.0092738-Higgins1">[41]</xref>. For the <italic>Q</italic> statistic, a <italic>P</italic>-value less than 0.1 was considered to be representative of statistically significant heterogeneity. <italic>I</italic><sup>2</sup> represents the proportion of total variation contributed by between-study variation <xref ref-type="bibr" rid="pone.0092738-Higgins1">[41]</xref>. The summary estimate was based on the fixed-effects model <xref ref-type="bibr" rid="pone.0092738-Higgins1">[41]</xref> when no heterogeneity was detected or the random-effects model <xref ref-type="bibr" rid="pone.0092738-DerSimonian1">[42]</xref> when substantial heterogeneity was detected. In both methods, the study weight was the inverse of the variance of log RR, which was estimated from the 95% CI from each study. Subgroup analyses were carried out based on study design (cohort vs. case-control studies), number of cases (≥200 (median) vs. &lt;200), type of controls for the case-control studies (population-based vs. hospital-based controls), geographic location (North America, Europe, or Asia). We also stratified the meta-analysis by potentially important confounders (i.e., body mass index (BMI), cigarette smoking, and Type 2 DM). Heterogeneity between subgroups was evaluated by meta-regression. A <italic>P</italic>-value less than 0.05 for meta-regression was considered representative of significant statistical difference between subgroups. Finally, we carried out sensitivity analyses excluding one study at a time to explore whether the results were strongly influenced by a specific study.</p>
<p>Publication bias was evaluated via Egger's linear regression <xref ref-type="bibr" rid="pone.0092738-Egger1">[43]</xref>, Begg's rank correlation methods <xref ref-type="bibr" rid="pone.0092738-Begg1">[44]</xref> and funnel plots. A <italic>P</italic>-value less than 0.05 for Egger's or Begg's tests was considered representative of significant statistical publication bias. Statistical analyses were performed with Stata (version 11.2; StataCorp, College Station, TX). <italic>P</italic>-values were two sided with a significance level of 0.05.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Study characteristics</title>
<p>Characteristics of the 22 included articles <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>–<xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, <xref ref-type="bibr" rid="pone.0092738-Bueno1">[30]</xref> are shown in <xref ref-type="supplementary-material" rid="pone.0092738.s001">Table S1</xref>. The included articles, which represent 8,247 cases and 3,498,673 non-cases, were published between 1992 and 2013 and consist of 11 prospective studies (9 cohort studies <xref ref-type="bibr" rid="pone.0092738-Lee1">[7]</xref>, <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>–<xref ref-type="bibr" rid="pone.0092738-Heuch1">[13]</xref>, <xref ref-type="bibr" rid="pone.0092738-Prizment1">[15]</xref>–<xref ref-type="bibr" rid="pone.0092738-Navarro1">[18]</xref>, <xref ref-type="bibr" rid="pone.0092738-Skinner1">[20]</xref> and two nested case-control studies <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>, <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref>) and 11 case-control studies <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>, <xref ref-type="bibr" rid="pone.0092738-Zhang1">[10]</xref>–<xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref>–<xref ref-type="bibr" rid="pone.0092738-Hanley1">[22]</xref>, <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref>–<xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, <xref ref-type="bibr" rid="pone.0092738-Bueno1">[30]</xref>. Of the 11 prospective studies, four were conducted in the United States <xref ref-type="bibr" rid="pone.0092738-Lee1">[7]</xref>, <xref ref-type="bibr" rid="pone.0092738-Prizment1">[15]</xref>, <xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref>, <xref ref-type="bibr" rid="pone.0092738-Skinner1">[20]</xref>, and one each in Taiwan <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, United Kingdom <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>, Norway <xref ref-type="bibr" rid="pone.0092738-Heuch1">[13]</xref>, Japan <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref>, Canada <xref ref-type="bibr" rid="pone.0092738-Navarro1">[18]</xref>, Sweden <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref>, and an international group which covered multiple countries <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>. Cohort sizes ranged from 37,459 <xref ref-type="bibr" rid="pone.0092738-Prizment1">[15]</xref> to 1,292,462 <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, and the number of PC cases varied from 154 <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref> to 1,959 <xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref>. The highest parity in the prospective studies varied from 3 <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref> to over 7 <xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref>.</p>
<p>Of the 11 case-control studies, three were conducted in the United States <xref ref-type="bibr" rid="pone.0092738-Zhang1">[10]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, two each in Italy <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>, <xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref> and Canada <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref>–<xref ref-type="bibr" rid="pone.0092738-Hanley1">[22]</xref>, and one each in Egypt <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>, China <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref>, and a study covering multiple countries <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>. The number of cases enrolled in these studies ranged from 56 <xref ref-type="bibr" rid="pone.0092738-LaVecchia2">[45]</xref> to 608 <xref ref-type="bibr" rid="pone.0092738-Lindblad1">[46]</xref>, and the number of control subjects varied from 52 <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref> to 367 <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>. Control subjects were drawn from the general population in 7 studies <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref>–<xref ref-type="bibr" rid="pone.0092738-Hanley1">[22]</xref>, <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, <xref ref-type="bibr" rid="pone.0092738-Bueno1">[30]</xref>, hospitals in 4 studies <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>, <xref ref-type="bibr" rid="pone.0092738-Zhang1">[10]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>, <xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref>, The highest parity in the case-control studies varied from 3 <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref> to over 7 <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>.</p>
</sec><sec id="s3b">
<title>High vs. low parity</title>
<p>Eleven prospective <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>–<xref ref-type="bibr" rid="pone.0092738-Lee1">[7]</xref>, <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>–<xref ref-type="bibr" rid="pone.0092738-Heuch1">[13]</xref>, <xref ref-type="bibr" rid="pone.0092738-Prizment1">[15]</xref>–<xref ref-type="bibr" rid="pone.0092738-Navarro1">[18]</xref>, <xref ref-type="bibr" rid="pone.0092738-Skinner1">[20]</xref>, <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref> and 11 case-control studies <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>, <xref ref-type="bibr" rid="pone.0092738-Zhang1">[10]</xref>–<xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref>–<xref ref-type="bibr" rid="pone.0092738-Hanley1">[22]</xref>, <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref>–<xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, <xref ref-type="bibr" rid="pone.0092738-Bueno1">[30]</xref> investigated the association between parity and PC risk. The summary RR of PC for the highest vs. lowest categories of parity was 0.86 (95% CI: 0.73–1.02), with significant heterogeneity (<italic>Q</italic> = 50.49, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup>  = 58.4%) (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref> and <xref ref-type="fig" rid="pone-0092738-g002">Figure 2</xref>). There was no indication of publication bias with Egger's test (<italic>P</italic> for bias  = 0.652) or with Begg's test (<italic>P</italic> for bias  = 0.324) and no asymmetry was seen in the funnel plots when inspected visually. In a sensitivity analysis, we sequentially removed one study at a time and re-analyzed the data. The 22 study-specific RRs of parity ranged from a low of 0.84 (95% CI: 0.71–0.98, <italic>Q</italic> = 42.53, <italic>P</italic> = 0.002, <italic>I</italic><sup>2</sup>  = 53.0%) after omission of the study by Ji et al <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref> to a high of 0.89 (95% CI: 0.76–1.05, <italic>Q</italic> = 45.98, <italic>P</italic> = 0.001, <italic>I</italic><sup>2</sup>  = 56.5%) after omission of the study by Lucenteforte et al. <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>.</p>
<fig id="pone-0092738-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092738.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot (random effects model) of parity (highest versus lowest) and pancreatic cancer risk by study design.</title>
<p>Squares indicate study-specific relative risks (size of the square reflects the study-specific statistical weight); horizontal lines indicate 95% CIs; diamond indicates the summary relative risk estimate with its 95% CI. CI: confidence interval; RR: relative risk.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092738.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0092738-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0092738.t001</object-id><label>Table 1</label><caption>
<title>Summary risk estimates of the association between parity and pancreatic cancer risk.</title>
</caption><alternatives><graphic id="pone-0092738-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0092738.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="6" align="left" rowspan="1">Highest versus lowest</td>
<td colspan="6" align="left" rowspan="1">Dose-response analysis (per 1 live birth)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No. of</td>
<td align="left" rowspan="1" colspan="1">Summary RR</td>
<td align="left" rowspan="1" colspan="1"><italic>Q</italic></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> Value</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>h</sub><xref ref-type="table-fn" rid="nt102">*</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>h</sub><xref ref-type="table-fn" rid="nt103">**</xref></td>
<td align="left" rowspan="1" colspan="1">No. of</td>
<td align="left" rowspan="1" colspan="1">Summary RR</td>
<td align="left" rowspan="1" colspan="1"><italic>Q</italic></td>
<td align="left" rowspan="1" colspan="1"><italic>I</italic><sup>2</sup> Value</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>h</sub><xref ref-type="table-fn" rid="nt102">*</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>h</sub><xref ref-type="table-fn" rid="nt103">**</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">studies</td>
<td align="left" rowspan="1" colspan="1">(95% CIs)</td>
<td align="left" rowspan="1" colspan="1">Statistic</td>
<td align="left" rowspan="1" colspan="1">(%)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">studies</td>
<td align="left" rowspan="1" colspan="1">(95% CIs)</td>
<td align="left" rowspan="1" colspan="1">Statistic</td>
<td align="left" rowspan="1" colspan="1">(%)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Overall</bold></td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.86 (0.73–1.02)</td>
<td align="left" rowspan="1" colspan="1">50.49</td>
<td align="left" rowspan="1" colspan="1">58.4</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">0.97 (0.94–1.01)</td>
<td align="left" rowspan="1" colspan="1">62.83</td>
<td align="left" rowspan="1" colspan="1">69.8</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Subgroup analyses</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Study Design</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.14</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prospective studies</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.92 (0.78–1.09)</td>
<td align="left" rowspan="1" colspan="1">18.5</td>
<td align="left" rowspan="1" colspan="1">45.9</td>
<td align="left" rowspan="1" colspan="1">0.047</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.95–1.03)</td>
<td align="left" rowspan="1" colspan="1">31.29</td>
<td align="left" rowspan="1" colspan="1">74.4</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Case-control studies</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.72 (0.50–1.05)</td>
<td align="left" rowspan="1" colspan="1">31.64</td>
<td align="left" rowspan="1" colspan="1">68.4</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.95 (0.90–1.01)</td>
<td align="left" rowspan="1" colspan="1">25.51</td>
<td align="left" rowspan="1" colspan="1">60.8</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Number of cases</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.08</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">&lt;200</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.71 (0.49–1.04)</td>
<td align="left" rowspan="1" colspan="1">24.19</td>
<td align="left" rowspan="1" colspan="1">62.8</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.95 (0.90–1.01)</td>
<td align="left" rowspan="1" colspan="1">23.11</td>
<td align="left" rowspan="1" colspan="1">61.1</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">≥200</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">0.92 (0.77–1.10)</td>
<td align="left" rowspan="1" colspan="1">26.15</td>
<td align="left" rowspan="1" colspan="1">57.9</td>
<td align="left" rowspan="1" colspan="1">0.0006</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.98 (0.95–1.02)</td>
<td align="left" rowspan="1" colspan="1">35.45</td>
<td align="left" rowspan="1" colspan="1">74.6</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Type of Control Subjects</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.25</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.38</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Population based</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.46–1.22)</td>
<td align="left" rowspan="1" colspan="1">21.24</td>
<td align="left" rowspan="1" colspan="1">71.8</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.94 (0.85–1.04)</td>
<td align="left" rowspan="1" colspan="1">20.59</td>
<td align="left" rowspan="1" colspan="1">70.9</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hospital based</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.67 (0.35–1.27)</td>
<td align="left" rowspan="1" colspan="1">9.44</td>
<td align="left" rowspan="1" colspan="1">68.2</td>
<td align="left" rowspan="1" colspan="1">0.024</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.96 (0.92–1.02)</td>
<td align="left" rowspan="1" colspan="1">4.80</td>
<td align="left" rowspan="1" colspan="1">37.6</td>
<td align="left" rowspan="1" colspan="1">0.187</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Geographic location</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.27</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.33</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">North America</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.81 (0.63–1.02)</td>
<td align="left" rowspan="1" colspan="1">17.93</td>
<td align="left" rowspan="1" colspan="1">49.8</td>
<td align="left" rowspan="1" colspan="1">0.036</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.97 (0.94–1.01)</td>
<td align="left" rowspan="1" colspan="1">17.3</td>
<td align="left" rowspan="1" colspan="1">48.0</td>
<td align="left" rowspan="1" colspan="1">0.044</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Europe</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.89 (0.65–1.22)</td>
<td align="left" rowspan="1" colspan="1">18.91</td>
<td align="left" rowspan="1" colspan="1">68.3</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.97 (0.90–1.04)</td>
<td align="left" rowspan="1" colspan="1">15.27</td>
<td align="left" rowspan="1" colspan="1">73.8</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asia</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.46–2.13)</td>
<td align="left" rowspan="1" colspan="1">10.27</td>
<td align="left" rowspan="1" colspan="1">80.5</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.86–1.14)</td>
<td align="left" rowspan="1" colspan="1">10.27</td>
<td align="left" rowspan="1" colspan="1">80.5</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td colspan="4" align="left" rowspan="1"><bold>Adjustment for confounders or important risk factors</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BMI</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.19</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">0.89 (0.71–1.12)</td>
<td align="left" rowspan="1" colspan="1">24.2</td>
<td align="left" rowspan="1" colspan="1">62.8</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.94–1.03)</td>
<td align="left" rowspan="1" colspan="1">21.58</td>
<td align="left" rowspan="1" colspan="1">62.9</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.63–1.08)</td>
<td align="left" rowspan="1" colspan="1">26.29</td>
<td align="left" rowspan="1" colspan="1">58.2</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">0.96 (0.91–1.01)</td>
<td align="left" rowspan="1" colspan="1">33.19</td>
<td align="left" rowspan="1" colspan="1">69.9</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cigarette smoking</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.70</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.90</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">0.81 (0.68–0.98)</td>
<td align="left" rowspan="1" colspan="1">36.71</td>
<td align="left" rowspan="1" colspan="1">53.7</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">0.97 (0.94–1.00)</td>
<td align="left" rowspan="1" colspan="1">30.30</td>
<td align="left" rowspan="1" colspan="1">47.2</td>
<td align="left" rowspan="1" colspan="1">0.016</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.09 (0.71–1.68)</td>
<td align="left" rowspan="1" colspan="1">10.98</td>
<td align="left" rowspan="1" colspan="1">72.7</td>
<td align="left" rowspan="1" colspan="1">0.012</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">0.99 (0.90–1.08)</td>
<td align="left" rowspan="1" colspan="1">11.23</td>
<td align="left" rowspan="1" colspan="1">82.2</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">DM</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.29</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">0.83 (0.75–0.93)</td>
<td align="left" rowspan="1" colspan="1">11.93</td>
<td align="left" rowspan="1" colspan="1">41.3</td>
<td align="left" rowspan="1" colspan="1">0.103</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">0.98 (0.96–1.00)</td>
<td align="left" rowspan="1" colspan="1">7.21</td>
<td align="left" rowspan="1" colspan="1">16.7</td>
<td align="left" rowspan="1" colspan="1">0.302</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">0.86 (0.65–1.13)</td>
<td align="left" rowspan="1" colspan="1">37.20</td>
<td align="left" rowspan="1" colspan="1">65.1</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.97 (0.92–1.02)</td>
<td align="left" rowspan="1" colspan="1">43.14</td>
<td align="left" rowspan="1" colspan="1">72.2</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BMI, Cigarette smoking, and Type 2 DM</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.16</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.16</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yes</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.85 (0.76–0.96)</td>
<td align="left" rowspan="1" colspan="1">7.89</td>
<td align="left" rowspan="1" colspan="1">36.6</td>
<td align="left" rowspan="1" colspan="1">0.162</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">0.98 (0.96–1.00)</td>
<td align="left" rowspan="1" colspan="1">4.85</td>
<td align="left" rowspan="1" colspan="1">17.5</td>
<td align="left" rowspan="1" colspan="1">0.303</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.63–1.06)</td>
<td align="left" rowspan="1" colspan="1">42.39</td>
<td align="left" rowspan="1" colspan="1">64.6</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">0.96 (0.92–1.01)</td>
<td align="left" rowspan="1" colspan="1">49.65</td>
<td align="left" rowspan="1" colspan="1">71.8</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>RR: relative risk; CI: confidence interval; BMI: body mass index; DM: diabetes mellitus.</p></fn><fn id="nt102"><label/><p><italic>* P</italic> value for heterogeneity within each subgroup.</p></fn><fn id="nt103"><label/><p><italic><sup>**</sup> P</italic> value for heterogeneity between subgroups with meta-regression analysis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c">
<title>Dose-response analysis</title>
<p>Nine prospective <xref ref-type="bibr" rid="pone.0092738-Duell1">[6]</xref>–<xref ref-type="bibr" rid="pone.0092738-Lee1">[7]</xref>, <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Prizment1">[15]</xref>–<xref ref-type="bibr" rid="pone.0092738-Navarro1">[18]</xref>, <xref ref-type="bibr" rid="pone.0092738-Skinner1">[20]</xref>, <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref> and 11 case-control studies <xref ref-type="bibr" rid="pone.0092738-Lucenteforte1">[8]</xref>, <xref ref-type="bibr" rid="pone.0092738-Zhang1">[10]</xref>–<xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lo1">[14]</xref>, <xref ref-type="bibr" rid="pone.0092738-Duell3">[19]</xref>, <xref ref-type="bibr" rid="pone.0092738-Kreiger1">[21]</xref>–<xref ref-type="bibr" rid="pone.0092738-Hanley1">[22]</xref>, <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref>–<xref ref-type="bibr" rid="pone.0092738-Fernandez1">[25]</xref>, <xref ref-type="bibr" rid="pone.0092738-Cantor1">[27]</xref>, <xref ref-type="bibr" rid="pone.0092738-Bueno1">[30]</xref> were included in the dose-response analysis. The summary RR per live birth was 0.97 (95% CI: 0.94–1.01), with significant of heterogeneity (<italic>Q</italic> = 62.83, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup>  = 69.8%) (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). In a sensitivity analysis excluding one study at a time, the summary RR for PC ranged from 0.97 (95% CI: 0.94–0.99, <italic>Q</italic> = 58.98, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup>  = 69.5%) when the study by Ji et al <xref ref-type="bibr" rid="pone.0092738-Ji1">[24]</xref> was excluded to 0.98 (95% CI: 0.95–1.01, <italic>Q</italic> = 56.29, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup>  = 68.0%) when the study by Chang et al <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref> was excluded. Additionally, the effect of excluding the two studies not included in the dose-response analysis on the summary RR for high vs. low parity was explored. The summary RR was 0.83 (95% CI: 0.68–1.00, <italic>Q</italic> = 43.60, <italic>P</italic> = 0.001, <italic>I</italic><sup>2</sup>  = 56.4%) which was similar to the original analysis including all studies. There was no evidence of a nonlinear association between parity and PC risk, <italic>P</italic> for nonlinearity  = 0.2409. Furthermore, when we removed three studies <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref>–<xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref> which reported the risk estimates from PC mortality, the results (RR, 0.98; 95% CI: 0.94–1.02, <italic>Q</italic> = 49.60, <italic>P</italic>&lt;0.001, <italic>I</italic><sup>2</sup>  = 67.7%) were similar.</p>
</sec><sec id="s3d">
<title>Subgroup analyses</title>
<p>In subgroup analyses of highest versus lowest categories of parity and PC risk, almost all strata showed inverse associations, although not all of them showed statistical significance. There was no evidence of significant heterogeneity between subgroups with meta-regression analyses (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). In the analyses stratified by whether the study included adjustment for specific potential confounders or important risk factors, significant inverse associations were observed in studies which adjusted for cigarette smoking, Type 2 DM, or all of the potential confounders (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). In addition, little heterogeneity was observed in the studies which adjusted for these aforementioned risk factors. Similar patterns were also observed in the dose-response analyses, but the results showed borderline statistical significance (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). Since mortality rate of PC could be confounded by survival related factors, we further excluded the mortality estimates by the studies reported the risk estimates with PC mortality <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref>–<xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref>, but the estimate (RR  = 0.89) were similar to the original analysis including all studies.</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>To our knowledge, this is the first meta-analysis which provide comprehensive and quantitative evidence of the association between parity and PC risk. In this study, high parity was associated with a borderline statistically significant decreased risk of PC although the decrease in risk was small for each additional live birth. In addition, consistent inverse associations were observed within the analyses stratified by whether the studies included adjustment for cigarette smoking, Type 2 DM, or all of the confounders or important risk factors (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>).</p>
<p>Although the exact biological mechanisms by which increased parity may decrease the risk of PC are not well established, a hypothesis that endogenous estrogens may be protective against PC has been proposed based on in-vitro and in-vivo studies <xref ref-type="bibr" rid="pone.0092738-Benz1">[3]</xref>, <xref ref-type="bibr" rid="pone.0092738-Longnecker1">[47]</xref>. Pregnancy elevates serum estrogen levels approximately 100-fold <xref ref-type="bibr" rid="pone.0092738-Yen1">[48]</xref>. Women with high parity are likely to have had longer periods of exposure to high levels of circulating estrogens which has been shown to inhibit the growth of preneoplastic pancreatic lesions or transplanted pancreatic carcinoma in rodent models <xref ref-type="bibr" rid="pone.0092738-Sumi1">[49]</xref>–<xref ref-type="bibr" rid="pone.0092738-Sumi2">[50]</xref>. In addition, sex-steroid biosynthetic enzymes (e.g., pancreatic homogenates and aromatase) and steroid hormone receptors have been detected in both normal and neoplastic human pancreatic tissue <xref ref-type="bibr" rid="pone.0092738-Iqbal1">[51]</xref>–<xref ref-type="bibr" rid="pone.0092738-Singh1">[54]</xref>. On the other hand, circulating insulin like growth factors (IGFs), which have been reported to increase PC risk through promoting cellular proliferation and inhibiting apoptosis <xref ref-type="bibr" rid="pone.0092738-LeRoith1">[55]</xref>, have been observed to be significantly lower in women with 4 births or more when compared with nulliparous women <xref ref-type="bibr" rid="pone.0092738-Holmes1">[56]</xref>.</p>
<p>Although the results of meta-regression found no evidence of significant heterogeneity between subgroups by study design, the strength of the association estimate for prospective studies was weaker than that from case-control studies although both of them showed inverse associations with PC risk (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). Given the extremely short median survival time of PC cases <xref ref-type="bibr" rid="pone.0092738-Jemal1">[57]</xref>, possible survival bias in case-control studies could be of concern. Furthermore, though parity is less prone to recall bias and misclassification <xref ref-type="bibr" rid="pone.0092738-Dahabreh1">[5]</xref>, the prospective studies enabled researchers to capture exposure information without the potential biases introduced by using proxy-interviews. For example, Duell et al <xref ref-type="bibr" rid="pone.0092738-Duell2">[11]</xref> reported a positive association with PC although the confidence interval included 1. In addition, because deaths from PC may be regarded as a reasonable indicator of the incidence of PC considering about the short survival time and rapidly fatal characteristic of this cancer <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Jemal1">[57]</xref>, this meta-analysis included four prospective studies <xref ref-type="bibr" rid="pone.0092738-Chang1">[9]</xref>, <xref ref-type="bibr" rid="pone.0092738-Stevens1">[12]</xref>, <xref ref-type="bibr" rid="pone.0092738-Lin1">[16]</xref>–<xref ref-type="bibr" rid="pone.0092738-Teras1">[17]</xref> which reported the risk estimates for PC mortality. Our results were similar when we excluded these four studies in a sensitivity analysis (data not shown).</p>
<p>When we pooled the results stratified by whether the studies included adjustment for confounders, statistically significant inverse associations were detected in studies which adjusted for cigarette smoking, type 2 DM, and those that included all potential confounders. Several established risk factors for PC, including obesity <xref ref-type="bibr" rid="pone.0092738-Rosenberg1">[58]</xref>–<xref ref-type="bibr" rid="pone.0092738-Williamson1">[59]</xref>, cigarette smoking <xref ref-type="bibr" rid="pone.0092738-Heuch1">[13]</xref>, <xref ref-type="bibr" rid="pone.0092738-Karlson1">[23]</xref>, and type 2 DM <xref ref-type="bibr" rid="pone.0092738-KritzSilverstein1">[60]</xref>–<xref ref-type="bibr" rid="pone.0092738-Nicholson1">[61]</xref> are associated with parity and therefore might confound the association between parity and PC risk. Although meta-regression found no significant difference between the studies that did or did not adjust for specific confounders, the results and heterogeneity were slightly different. Compared to the high heterogeneity (<italic>Q</italic> = 65.1, P&lt;0.001) which was observed among the studies did not adjust for type 2 DM, the summary results in these studies adjusted for aforementioned confounders had low heterogeneity. Similar pattern was also observed in the studies whether adjusted for the three confounders (BMI, cigarette smoking, and type 2 DM) (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). However, considering that only a third of studies adjusted for type 2 DM and a quarter adjusted for the three confounders, future studies need to carefully adjust for these potential confounders or report analyses stratified by these risk factors to better be able to rule out residual confounding.</p>
<p>This study had several strengths. To the best of our knowledge, this is the first comprehensive and quantitative assessment of parity and PC. Particular strengths of the current meta-analysis are that it including a total of 8,247 cases and 3,498,673 non-cases which should have provided sufficient statistical power to detect this putative association. A further strength is that we carried out a number of subgroup and sensitivity analyses to explore the potential sources of heterogeneity.</p>
<p>Potential limitations of this meta-analysis must be taken into consideration. First, as a meta-analysis of epidemiological studies, this study contains the limitations inherent to combining results from studies with heterogeneous study designs. Cohort studies are less susceptible to bias (e.g., recall and selection bias) than case-control studies because, due to the prospective design, information on exposures is collected before the diagnosis of the disease. Additionally, given the possible differences in detailed confounder adjustment information over time, we also carried out the stratified analysis by published year, but the results were unchanged (data not shown). Second, since we did not have access to the primary data of the studies included in this meta-analysis, we could not perform additional adjustments for potentially important covariates or accurately assign an exposure value to open-ended parity categories <xref ref-type="bibr" rid="pone.0092738-IlYasova1">[62]</xref>. However, this is a common limitation in studies of dose-response relationships based on aggregate data. In addition, since the quality scoring in a meta-analysis of observational studies is controversial, lacks demonstrated validity, and results may not be associated with quality <xref ref-type="bibr" rid="pone.0092738-Greenland2">[63]</xref>, we did not use the Newcastle-Ottawa Scale <xref ref-type="bibr" rid="pone.0092738-Wells1">[64]</xref>–<xref ref-type="bibr" rid="pone.0092738-Luan1">[65]</xref> to assess the methodological quality of included studies. Instead, we carried out numerous subgroup and sensitivity analyses. Third, significant heterogeneity and possible publication bias must be considered. There was significant heterogeneity for all studies combined in the analysis of high vs. low parity, as well as in the dose-response analysis, which could be explained by many factors, mainly the differences in confounder adjustment (<xref ref-type="table" rid="pone-0092738-t001">Table 1</xref>). In addition, publication bias can be a problem in meta-analyses of published studies; however, we found no statistical evidence of publication bias in this meta-analysis by Egger's linear regression and Begg's rank correlation methods, and there did not appear to be asymmetry in the funnel plots when inspected visually.</p>
<p>In conclusion, this comprehensive meta-analysis provides evidence that increased parity is associated with a slightly decreased risk of PC. Although this relative risk is moderate in size, given the limited established risk factors and low survival rate, further large consortia or pooled studies, are warranted to fully adjust for the potential confounders and focus on the sex-steroid related factors which might play a role in the development of PC malignancies.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0092738.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0092738.s001" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Characteristics of studies of parity and pancreatic cancer risk.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pone.0092738.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0092738.s002" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA 2009 Checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0092738-Siegel1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Naishadham</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name> (<year>2013</year>) <article-title>Cancer statistics, 2013</article-title>. <source>CA Cancer J Clin</source> <volume>63</volume>: <fpage>11</fpage>–<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Anderson1"><label>2</label>
<mixed-citation publication-type="other" xlink:type="simple">Anderson KE, Mack TM, Silverman DT (2006) Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press:721–762.</mixed-citation>
</ref>
<ref id="pone.0092738-Benz1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Benz</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hollander</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>B</given-names></name> (<year>1986</year>) <article-title>Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines</article-title>. <source>Cancer Res</source> <volume>46</volume>: <fpage>2276</fpage>–<lpage>2281</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Bourhis1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bourhis</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lacaine</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Augusti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Huguier</surname><given-names>M</given-names></name> (<year>1987</year>) <article-title>Protective effect of oestrogen in pancreatic cancer</article-title>. <source>Lancet</source> <volume>2</volume>: <fpage>977</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Dahabreh1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dahabreh</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Trikalinos</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Paulus</surname><given-names>JK</given-names></name> (<year>2012</year>) <article-title>Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies</article-title>. <source>Lung Cancer</source> <volume>76</volume>: <fpage>150</fpage>–<lpage>158</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Duell1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duell</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Travier</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lujan-Barroso</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dossus</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Boutron-Ruault</surname><given-names>MC</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort</article-title>. <source>Int J Cancer</source> <volume>132</volume>: <fpage>2164</fpage>–<lpage>2175</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Lee1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Horn-Ross</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Rull</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Neuhausen</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Anton-Culver</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Reproductive Factors, Exogenous Hormones, and Pancreatic Cancer Risk in the CTS</article-title>. <source>Am J Epidemiol</source> <volume>178</volume>: <fpage>1403</fpage>–<lpage>1413</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Lucenteforte1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lucenteforte</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zucchetto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bosetti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Talamini</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Negri</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Reproductive and hormonal factors and pancreatic cancer risk in women</article-title>. <source>Pancreas</source> <volume>40</volume>: <fpage>460</fpage>–<lpage>463</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Chang1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CY</given-names></name> (<year>2010</year>) <article-title>Parity, age at first birth, and risk of death from pancreatic cancer: evidence from a cohort in Taiwan</article-title>. <source>Pancreas</source> <volume>39</volume>: <fpage>567</fpage>–<lpage>571</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Zhang1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Coogan</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Strom</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>L</given-names></name> (<year>2010</year>) <article-title>A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer</article-title>. <source>Cancer Causes Control</source> <volume>21</volume>: <fpage>473</fpage>–<lpage>478</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Duell2"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duell</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Maisonneuve</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Baghurst</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Bueno-de-Mesquita</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Ghadirian</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC</article-title>. <source>Cancer Causes Control</source> <volume>20</volume>: <fpage>1757</fpage>–<lpage>1762</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Stevens1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stevens</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Roddam</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pirie</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bull</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>18</volume>: <fpage>1457</fpage>–<lpage>1460</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Heuch1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heuch</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jacobsen</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Albrektsen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kvale</surname><given-names>G</given-names></name> (<year>2008</year>) <article-title>Reproductive factors and pancreatic cancer risk: a Norwegian cohort study</article-title>. <source>Br J Cancer</source> <volume>98</volume>: <fpage>189</fpage>–<lpage>193</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Lo1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lo</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Soliman</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>El-Ghawalby</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Abdel-Wahab</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fathy</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk</article-title>. <source>Pancreas</source> <volume>35</volume>: <fpage>120</fpage>–<lpage>129</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Prizment1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prizment</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></name> (<year>2007</year>) <article-title>Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study</article-title>. <source>JOP</source> <volume>8</volume>: <fpage>16</fpage>–<lpage>27</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Lin1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kikuchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tamakoshi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kawamura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Inaba</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk</article-title>. <source>J Gastroenterol</source> <volume>41</volume>: <fpage>878</fpage>–<lpage>883</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Teras1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teras</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Thun</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Calle</surname><given-names>EE</given-names></name> (<year>2005</year>) <article-title>Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States)</article-title>. <source>Cancer Causes Control</source> <volume>16</volume>: <fpage>1035</fpage>–<lpage>1040</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Navarro1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Navarro</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Rohan</surname><given-names>TE</given-names></name> (<year>2005</year>) <article-title>Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study</article-title>. <source>Pancreas</source> <volume>30</volume>: <fpage>369</fpage>–<lpage>374</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Duell3"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duell</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Holly</surname><given-names>EA</given-names></name> (<year>2005</year>) <article-title>Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women</article-title>. <source>Am J Epidemiol</source> <volume>161</volume>: <fpage>741</fpage>–<lpage>747</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Skinner1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skinner</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Michaud</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Colditz</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Stampfer</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Parity, reproductive factors, and the risk of pancreatic cancer in women</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>12</volume>: <fpage>433</fpage>–<lpage>438</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Kreiger1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kreiger</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lacroix</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sloan</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Hormonal factors and pancreatic cancer in women</article-title>. <source>Ann Epidemiol</source> <volume>11</volume>: <fpage>563</fpage>–<lpage>567</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Hanley1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hanley</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Villeneuve</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>Y</given-names></name> (<year>2001</year>) <article-title>Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system</article-title>. <source>Int J Cancer</source> <volume>94</volume>: <fpage>140</fpage>–<lpage>147</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Karlson1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karlson</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Wuu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Lambe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ekbom</surname><given-names>A</given-names></name> (<year>1998</year>) <article-title>Parity and the risk of pancreatic cancer: a nested case-control study</article-title>. <source>Int J Cancer</source> <volume>77</volume>: <fpage>224</fpage>–<lpage>227</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Ji1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ji</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Hatch</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>McLaughlin</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Q</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China</article-title>. <source>Int J Cancer</source> <volume>66</volume>: <fpage>432</fpage>–<lpage>437</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Fernandez1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fernandez</surname><given-names>E</given-names></name>, <name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>D'Avanzo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Negri</surname><given-names>E</given-names></name> (<year>1995</year>) <article-title>Menstrual and reproductive factors and pancreatic cancer risk in women</article-title>. <source>Int J Cancer</source> <volume>62</volume>: <fpage>11</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Kvale1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kvale</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Heuch</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Nilssen</surname><given-names>S</given-names></name> (<year>1994</year>) <article-title>Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women</article-title>. <source>Int J Epidemiol</source> <volume>23</volume>: <fpage>691</fpage>–<lpage>699</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Cantor1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cantor</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>D</given-names></name> (<year>1993</year>) <article-title>Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States)</article-title>. <source>Cancer Causes Control</source> <volume>4</volume>: <fpage>505</fpage>–<lpage>511</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Kalapothaki1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kalapothaki</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Tzonou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Toupadaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Karakatsani</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma</article-title>. <source>Cancer Causes Control</source> <volume>4</volume>: <fpage>375</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-LaVecchia1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Negri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Franceschi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Parazzini</surname><given-names>F</given-names></name> (<year>1993</year>) <article-title>Long-term impact of reproductive factors on cancer risk</article-title>. <source>Int J Cancer</source> <volume>53</volume>: <fpage>215</fpage>–<lpage>219</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Bueno1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bueno</surname><given-names>DMH</given-names></name>, <name name-style="western"><surname>Maisonneuve</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Moerman</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>AM</given-names></name> (<year>1992</year>) <article-title>Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands</article-title>. <source>Int J Cancer</source> <volume>52</volume>: <fpage>24</fpage>–<lpage>29</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Haines1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haines</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Whittemore</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Quivey</surname><given-names>J</given-names></name> (<year>1982</year>) <article-title>A case-control study of pancreatic carcinoma</article-title>. <source>J Cancer Res Clin Oncol</source> <volume>103</volume>: <fpage>93</fpage>–<lpage>97</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Miller1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Barclay</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>NW</given-names></name>, <name name-style="western"><surname>Grace</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Wall</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>1980</year>) <article-title>A study of cancer, parity and age at first pregnancy</article-title>. <source>J Chronic Dis</source> <volume>33</volume>: <fpage>595</fpage>–<lpage>605</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Wahi1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wahi</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schrock</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Rosemurgy</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Goldin</surname><given-names>SB</given-names></name> (<year>2009</year>) <article-title>Reproductive factors and risk of pancreatic cancer in women: a review of the literature</article-title>. <source>Ann Epidemiol</source> <volume>19</volume>: <fpage>103</fpage>–<lpage>111</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Moher1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2009</year>) <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>BMJ</source> <volume>339</volume>: <fpage>b2535</fpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Wu1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Vogtmann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>HL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis</article-title>. <source>Ann Oncol</source> <volume>24</volume>: <fpage>1918</fpage>–<lpage>1924</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Guan1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guan</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>TT</given-names></name> (<year>2013</year>) <article-title>Parity and kidney cancer risk: evidence from epidemiologic studies</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>22</volume>: <fpage>2345</fpage>–<lpage>2353</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Hamling1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hamling</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Weitkunat</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ambuhl</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category</article-title>. <source>Stat Med</source> <volume>27</volume>: <fpage>954</fpage>–<lpage>970</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Greenland1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenland</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Longnecker</surname><given-names>MP</given-names></name> (<year>1992</year>) <article-title>Methods for trend estimation from summarized dose-response data, with applications to meta-analysis</article-title>. <source>Am J Epidemiol</source> <volume>135</volume>: <fpage>1301</fpage>–<lpage>1309</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Royston1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Royston</surname><given-names>P</given-names></name> (<year>2000</year>) <article-title>A strategy for modelling the effect of a continuous covariate in medicine and epidemiology</article-title>. <source>Stat Med</source> <volume>19</volume>: <fpage>1831</fpage>–<lpage>1847</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Bagnardi1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bagnardi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Zambon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Quatto</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Corrao</surname><given-names>G</given-names></name> (<year>2004</year>) <article-title>Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality</article-title>. <source>Am J Epidemiol</source> <volume>159</volume>: <fpage>1077</fpage>–<lpage>1086</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Higgins1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name> (<year>2002</year>) <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-DerSimonian1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Egger1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Begg1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-LaVecchia2"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Negri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Franceschi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Parazzini</surname><given-names>F</given-names></name> (<year>1993</year>) <article-title>Long-term impact of reproductive factors on cancer risk</article-title>. <source>Int J Cancer</source> <volume>53</volume>: <fpage>215</fpage>–<lpage>219</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Lindblad1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindblad</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mellemgaard</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schlehofer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Adami</surname><given-names>HO</given-names></name>, <name name-style="western"><surname>McCredie</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones</article-title>. <source>Int J Cancer</source> <volume>61</volume>: <fpage>192</fpage>–<lpage>198</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Longnecker1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Longnecker</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Sumi</surname><given-names>C</given-names></name> (<year>1990</year>) <article-title>Effects of sex steroid hormones on pancreatic cancer in the rat</article-title>. <source>Int J Pancreatol</source> <volume>7</volume>: <fpage>159</fpage>–<lpage>165</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Yen1"><label>48</label>
<mixed-citation publication-type="other" xlink:type="simple">Yen SS (1994) Endocrinology of pregnancy. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. 3rd ed. Philadelphia, PA: Saunders:382–412.</mixed-citation>
</ref>
<ref id="pone.0092738-Sumi1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sumi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Longnecker</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Roebuck</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Brinck-Johnsen</surname><given-names>T</given-names></name> (<year>1989</year>) <article-title>Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine</article-title>. <source>Cancer Res</source> <volume>49</volume>: <fpage>2332</fpage>–<lpage>2336</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Sumi2"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sumi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Brinck-Johnsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Longnecker</surname><given-names>DS</given-names></name> (<year>1989</year>) <article-title>Inhibition of a transplantable pancreatic carcinoma by castration and estradiol administration in rats</article-title>. <source>Cancer Res</source> <volume>49</volume>: <fpage>6687</fpage>–<lpage>6692</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Iqbal1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iqbal</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Greenway</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wilkinson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>R</given-names></name> (<year>1983</year>) <article-title>Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue</article-title>. <source>Clin Sci (Lond)</source> <volume>65</volume>: <fpage>71</fpage>–<lpage>75</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-AndrenSandberg1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andren-Sandberg</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hoem</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Backman</surname><given-names>PL</given-names></name> (<year>1999</year>) <article-title>Other risk factors for pancreatic cancer: hormonal aspects</article-title>. <source>Ann Oncol</source> <volume>10</volume> Suppl 4<fpage>131</fpage>–<lpage>135</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Greenway1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenway</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Iqbal</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>R</given-names></name> (<year>1981</year>) <article-title>Oestrogen receptor proteins in malignant and fetal pancreas</article-title>. <source>Br Med J (Clin Res Ed)</source> <volume>283</volume>: <fpage>751</fpage>–<lpage>753</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Singh1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Poulsom</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Sheppard</surname><given-names>MC</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer</article-title>. <source>Br J Surg</source> <volume>84</volume>: <fpage>1085</fpage>–<lpage>1089</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-LeRoith1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LeRoith</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>CJ</given-names></name> (<year>2003</year>) <article-title>The insulin-like growth factor system and cancer</article-title>. <source>Cancer Lett</source> <volume>195</volume>: <fpage>127</fpage>–<lpage>137</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Holmes1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holmes</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Pollak</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Hankinson</surname><given-names>SE</given-names></name> (<year>2002</year>) <article-title>Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>11</volume>: <fpage>862</fpage>–<lpage>867</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Jemal1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Clegg</surname><given-names>LX</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ries</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival</article-title>. <source>Cancer</source> <volume>101</volume>: <fpage>3</fpage>–<lpage>27</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Rosenberg1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenberg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Wise</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Kumanyika</surname><given-names>SK</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>A prospective study of the effect of childbearing on weight gain in African-American women</article-title>. <source>Obes Res</source> <volume>11</volume>: <fpage>1526</fpage>–<lpage>1535</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Williamson1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williamson</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Madans</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pamuk</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Flegal</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kendrick</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age</article-title>. <source>Int J Obes Relat Metab Disord</source> <volume>18</volume>: <fpage>561</fpage>–<lpage>569</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-KritzSilverstein1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kritz-Silverstein</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Barrett-Connor</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wingard</surname><given-names>DL</given-names></name> (<year>1989</year>) <article-title>The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance</article-title>. <source>N Engl J Med</source> <volume>321</volume>: <fpage>1214</fpage>–<lpage>1219</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Nicholson1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nicholson</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Asao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brancati</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Coresh</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pankow</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study</article-title>. <source>Diabetes Care</source> <volume>29</volume>: <fpage>2349</fpage>–<lpage>2354</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-IlYasova1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Il'Yasova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hertz-Picciotto</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Berlin</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Poole</surname><given-names>C</given-names></name> (<year>2005</year>) <article-title>Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem</article-title>. <source>Cancer Causes Control</source> <volume>16</volume>: <fpage>383</fpage>–<lpage>388</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Greenland2"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenland</surname><given-names>S</given-names></name> (<year>1994</year>) <article-title>Invited commentary: a critical look at some popular meta-analytic methods</article-title>. <source>Am J Epidemiol</source> <volume>140</volume>: <fpage>290</fpage>–<lpage>296</lpage>.</mixed-citation>
</ref>
<ref id="pone.0092738-Wells1"><label>64</label>
<mixed-citation publication-type="other" xlink:type="simple">Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>. Accessed October 1, 2013.</mixed-citation>
</ref>
<ref id="pone.0092738-Luan1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luan</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Vogtmann</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies</article-title>. <source>Am J Clin Nutr</source> <volume>98</volume>: <fpage>1020</fpage>–<lpage>1031</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>